Testing effectiveness (Phase 2)Study completedNCT02678741
What this trial is testing
Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.
Who this might be right for
Metastatic Melanoma
Elios Therapeutics, LLC 26